Related Experiment Video
Updated: Jul 7, 2026

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway
Published on: May 10, 2024
Transforming growth factor-beta1 and Smad4 signaling pathway down-regulates renal extracellular matrix degradation in
Qin Yang1, Ru-jia Xie, Ting Yang
1Department of Pathophysiology, Guiyang Medical College, Guiyang. qinyang@gmc.edu.cn
Objective:
To investigate the role of transforming growth factor-beta1 (TGF-beta1)/Smad4 pathway in development of renal fibrosis in streptozotocin (STZ)-induced diabetic nephropathy (DN) rats and explore its possible mechanism.
Methods:
Male Wistar rats weighing 180-220 g were divided into 5 groups: group A (normal control), group B [diabetes mellitus (DM) 2 weeks], group C (DM 4 weeks), group D (DM 8 weeks), and group E (DM 16 weeks). Except for the normal control group, other groups were induced DM by single injection of STZ (55 mg/kg) respectively. Blood glucose level, serum creatinine, and 24-hour urine protein were examined. Expressions of TGF-beta1 and Smad4 protein and mRNA in kidney were detected using immunohistochemical technique, Western blot, and real-time PCR. mRNA expressions of stromelysin-1 (MMP-3), tissue inhibitor of metalloproteinase-1 (TIMP-1), and collagen In in kidney were also detected by real-time PCR.
Results:
The levels of blood glucose, serum creatinine, and 24-hour urine protein in rats of group B, C, D, and E were higher than those of the control group. With the progression of renal fibrosis, the expressions of TGF-beta1 and Smad4 protein and mRNA in kidney of diabetic rats elevated. In addition, the renal MMP-3 mRNA expression diminished in diabetic rats, while TIMP-1 and collagen III mRNA increased.
Conclusions:
In STZ-induced diabetic rats, the TGF-beta1/Smad4 appears to play an important role in renal fibrosis of DN. The increased expression of TGF-beta1 and Smad4 might result in the transcriptional regulation of downstream target genes of TGF-beta1/Smad4 pathway, which contributes to the progression of renal fibrosis in diabetic rats.
Insights
The transforming growth factor-beta1 (TGF-beta1)/Smad4 pathway is crucial in diabetic nephropathy (DN) renal fibrosis. This pathway
Area of Science:
- Nephrology
- Endocrinology
- Molecular Biology
Background:
- Diabetic nephropathy (DN) is a major complication of diabetes mellitus.
- Renal fibrosis is a hallmark of DN progression.
- The TGF-beta1/Smad4 signaling pathway is implicated in fibrotic diseases.
Purpose of the Study:
- To investigate the role of the TGF-beta1/Smad4 pathway in STZ-induced DN.
- To explore the molecular mechanisms underlying renal fibrosis in DN.
Main Methods:
- Streptozotocin (STZ)-induced diabetic rat model.
- Assessment of kidney function markers (serum creatinine, urine protein).
- Quantification of TGF-beta1, Smad4, MMP-3, TIMP-1, and collagen III expression via immunohistochemistry, Western blot, and real-time PCR.
Main Results:
- STZ-induced diabetes elevated blood glucose, serum creatinine, and urine protein.
- Increased expression of TGF-beta1 and Smad4 in diabetic rat kidneys.
- Downregulation of MMP-3 and upregulation of TIMP-1 and collagen III mRNA in diabetic kidneys.
Conclusions:
- The TGF-beta1/Smad4 pathway plays a significant role in renal fibrosis in STZ-induced DN.
- Upregulation of TGF-beta1 and Smad4 contributes to renal fibrosis progression via downstream gene regulation.
Related Concept Videos
TGF - β Signaling Pathway
Diabetic Nephropathy
Regulation of Angiogenesis and Blood Supply
Role of Matrix Metalloproteases in Degradation of ECM
A...
